Life After Cancer

Cancervive is an organization that helps cancer survivors overcome the challenges of “life after cancer.” In addition to support groups, they provide educational materials, insurance information and assistance and advocacy.

At first, I didn’t get it. Why worry about life after cancer? What’s there to worry about?

For some families, having a child with cancer has wiped them out financially and college scholarships specifically targeting young cancer survivors can help.

The Cancer Survival Fund can help (http://www.cancersurvivorsfund.org/) They envision to reach every young cancer survivor who is actively seeking for a scholarship and/or financial assistance to obtain prosthetics needing our help to continue their education for personal growth and better, brighter future.

What about a caregiver fired for providing care for a loved one with cancer? Cancervive’s legal counsel offers support and advice like this: “It is illegal to discriminate against someone who has a handicapping condition, and also against someone, such as yourself, who is assisting or wants to assist someone who has a handicapping condition” and tells readers what to do next.

Cancervive

800-486-2873

www.cancervive.org

Blog Category: 

More Articles

More Articles

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

In a large trial of older, newly diagnosed patients with chronic lymphocytic leukemia (CLL),...

Today’s typical treatments have been unable to cure numerous types of lymphoma, but emerging immunotherapies could provide the key to...

Biotech firm Gilead Sciences Inc. has announced that the first patient has been dosed in a Phase III trial evaluating the safety and efficacy of...

Last week at the 54th American Society of Hematology Annual Meeting and Exposition in Atlanta, researchers out of MD Anderson Cancer Center in...

The results of a pair of long-term survival studies indicate the therapeutic value of BEXXAR (...

A new lab test that can improve survival rates among patients with chronic lymphocytic leukemia (...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Sitemap